Literature DB >> 11377116

A comparison of three measures: the time trade-off technique, global health-related quality of life and the SF-36 in dialysis patients.

Y Maor1, M King, L Olmer, B Mozes.   

Abstract

We investigated the correlation between descriptive and valuational measures of health-related quality of life (HRQL) and assessed determinants affecting these measures. Our suspicion was that there is little similarity in the content of descriptive and valuational measures of HRQL. We thus conducted a cross-sectional observational study of 56 hemodialysis patients. All underwent structured interviews. Dependent variables were patients utilities [time trade-off (TTO)], global rating of HRQL and generic HRQL (SF-36). Independent variables were socioeconomic details, disease severity, comorbidity, symptoms, depression, social support, and laboratory data. The correlation between TTO and global HRQL was -0.33 (P = .0178) and between TTO and the SF-36 physical and mental summary scores -0.16 (P = .2383) and -0.20 (P = .1443), respectively. The regression models for the SF-36 physical and mental summary scores explained 75% and 64% of the variance, and for global HRQL 29% of the variance. The independent variables had no effect on the TTO. This confirmed our suspicion that a qualitative difference exists between TTO and descriptive quality of life tools. The TTO content could not be explained by the variables that entail the content of HRQL instruments.

Entities:  

Mesh:

Year:  2001        PMID: 11377116     DOI: 10.1016/s0895-4356(00)00338-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

Review 1.  Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research.

Authors:  Patricia Cubi-Molla; Koonal Shah; Kristina Burström
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

Review 2.  Generic health-related quality-of-life assessment in children and adolescents: methodological considerations.

Authors:  Ulrike Ravens-Sieberer; Michael Erhart; Nora Wille; Ralf Wetzel; Jennifer Nickel; Monika Bullinger
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Construct validity of the interview time trade-off and computer time trade-off in patients with rheumatoid arthritis: a cross-sectional observational pilot study.

Authors:  Laurien Buitinga; Louise Ma Braakman-Jansen; Erik Taal; Mart Afj van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2012-06-25       Impact factor: 2.362

4.  Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.

Authors:  Nick Kontodimopoulos; Dimitris Niakas
Journal:  BMC Health Serv Res       Date:  2006-01-14       Impact factor: 2.655

5.  The effects of an interventional program based on self-care model on health-related quality of life outcomes in hemodialysis patients.

Authors:  Mohammadkarim Bahadori; Fatemeh Ghavidel; Shahla Mohammadzadeh; Ramin Ravangard
Journal:  J Educ Health Promot       Date:  2014-11-29

6.  Computer-Assessed Preference-Based Quality of Life in Patients with Spinal Cord Injury.

Authors:  Enea Parimbelli; Caterina Pistarini; Gabriella Fizzotti; Carla Rognoni; Giampiero Olivieri; Silvana Quaglini
Journal:  Biomed Res Int       Date:  2017-08-30       Impact factor: 3.411

7.  Prevalence and associated factors of self-treatment behaviour among different elder subgroups in rural China: a cross-sectional study.

Authors:  Wanchun Xu; Zhong Li; Zijing Pan; Ruibo He; Liang Zhang
Journal:  Int J Equity Health       Date:  2020-03-12

8.  Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.

Authors:  Marie-Louise Essink-Bot; Marja C Stuifbergen; Willem-Jan Meerding; Caspar W N Looman; Gouke J Bonsel
Journal:  BMC Health Serv Res       Date:  2007-04-27       Impact factor: 2.655

9.  A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.

Authors:  Panagiotis Petrou; Michael A Talias
Journal:  Cost Eff Resour Alloc       Date:  2014-05-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.